The National Academies of Science, Engineering and Medicine report Breaking Through, released Thursday, represents an important first step toward ensuring that the United States has the scientific workforce needed to face 21st-century infectious disease challenges.
Infectious diseases (ID) specialists play a vital role in many areas of healthcare but their compensation ranks towards the bottom compared to other physicians.
The 2018 Annual Report to Congress released by the United States President’s Emergency Plan for AIDS Relief tells a story of remarkable progress and opportunity.
The 2018 Annual Report to Congress released by the United States President’s Emergency Plan for AIDS Relief tells a story of remarkable progress and opportunity.
On World Health Day, the Infectious Diseases Society of America and the HIV Medicine Association appreciate the global leadership of the United States in responding to infectious disease threats that know no boundaries.
On World Health Day, the Infectious Diseases Society of America and the HIV Medicine Association appreciate the global leadership of the United States in responding to infectious disease threats that know no boundaries.
As a leader of efforts to stem the spread of antibiotic resistance, the Infectious Diseases Society of America recognizes both the important progress and the pressing needs reflected in the Vital Signs report, Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms, released by the U.S. Centers for Disease Control and Prevention today.
Critical research and programmatic responses require maintaining and in many cases increasing support.
Commemoration of World TB Day finds us at a promising but pivotal moment.
The national opioid crisis is fueling a rise in infectious diseases including HIV, viral hepatitis and bacterial infections such as infective endocarditis and musculoskeletal infections.
The Infectious Diseases Society of America stands ready to work with Dr. Robert Redfield as he takes the helm of the Centers for Disease Control and Prevention.
When infectious diseases (ID) specialists were involved in the care of patients with certain kinds of drug-resistant infections, the patients’ 30-day mortality rates were about 50 percent lower, according to a new study published in Open Forum Infectious Diseases.